Vaccine News and Research

Latest Vaccine News and Research

How have human organoids been used in research to study SARS-CoV-2?

In a recent review published in the journal Organoids, scientists have presented an overview on the use of human stem cell-derived organoids in understanding functionality and cellular tropism of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), a deadly beta-coronavirus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic.

7 Mar 2022

French study shows COVID vaccine efficacy 94% against severe outcomes

A recent paper published on the medRxiv preprint server utilized data from three national databases containing an abundance of information on Covid-19 screening (SI-DEP), vaccination (VAC-SI), and hospitalizations (SI-VIC) in France to provide additional perspectives on vaccine effectiveness and its evolution over the year 2021 in the French context.

7 Mar 2022

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases--enzymes that allow SARS-CoV-2 to reproduce--they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

7 Mar 2022

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

Scientists hypothesize that antibody-specific responses vary during vaccine breakthrough infections in a variant-specific manner.

7 Mar 2022

Delta and Omicron coinfections identified in France

A new study shows both the Omicron and Delta variants were able to infect patients with healthy immune function.

7 Mar 2022

Physicians' knowledge, attitudes, and preventative practices regarding the COVID-19 pandemic

Researchers conducted a global survey to assess the knowledge, attitudes, and practices of physicians towards COVID-19.

7 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

7 Mar 2022

Study examines whether knowledge of virus-neutralizing antibody titer impacted wellness decision-making

Researchers evaluated the impact of virus-neutralizing antibody titers against SARS-CoV-2 knowledge on deciding the timing of booster vaccination and social behavior.

7 Mar 2022

Watch: California’s top health adviser on learning to live with covid

Dr. Mark Ghaly, head of California's massive Health and Human Services Agency, continues to wear a mask in grocery stores and will dine outside — but not indoors — at restaurants even as California, like much of the nation, has lifted its mask mandate and many other pandemic restrictions.

7 Mar 2022

Study explores COVID-19 vaccine effectiveness in ankylosing spondylitis patients

Researchers estimated the immunogenicity of SARS-CoV-2 vaccination in a Belgian cohort of patients with ankylosing spondylitis.

7 Mar 2022

Binding efficacy of SARS-CoV-2 S1 specific salivary antibodies to the Omicron and Delta variants

A recent study assessed the varying affinities of SARS-CoV-2 antibodies to the SARS-CoV-2 Omicron and Delta variants of concern in vaccinated and convalescent individuals.

7 Mar 2022

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

In January, the Centers for Disease Control and Prevention (CDC) updated its guidance for reducing SARS-CoV-2 (COVID-19) transmission in schools and day care settings.

6 Mar 2022

Myocarditis and pericarditis in COVID-19 vaccine recipients

A new study provides valuable evidence towards this end, using surveillance data to provide the best estimates of these outcomes.

6 Mar 2022

Combating COVID cytokine storm with targeted nucleic acid therapies

Researchers examine current nucleic acid-based treatments against COVID-19 and their methods of action.

6 Mar 2022

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

An new study reports that a third dose of the Pfizer BNT162b2 vaccine produces high levels of anti-spike IgG antibodies in kidney transplant recipients.

6 Mar 2022

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Researchers develop an Omicron variant mRNA vaccine that is be more potent in generating nAbs as compared to other available vaccines.

6 Mar 2022

When teens blow off parents’ pleas to get vaccinated, the consequences can be deadly

Kennedy Stonum, a high school junior, deflected repeated entreaties from her father to please just get vaccinated against covid-19.

4 Mar 2022

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Researchers evaluate the feasibility and robustness of an optimized RT-LAMP SARS-CoV-2 detection assay across multiple resource-restricted settings.

4 Mar 2022

COVID-19 and the life sciences; what have we learned and where are we going?

News-Medical attended the 2022 SLAS press briefing where Peter Simpson, Michael Girardi, and Simon Meffan-Main gave their thoughts on the life sciences sector post-COVID-19.

From Society for Laboratory Automation and Screening (SLAS) 4 Mar 2022

Over a third vaccinated-but-unboosted adults have reservations about vaccinating children

While the vast majority of U.S. adults who are fully vaccinated and boosted against Covid-19 would be likely to recommend vaccinating a 5- to 11-year-old, over a third of fully vaccinated adults who have not had a booster shot have reservations about Covid-19 vaccination for a child that age, according to survey data analysis by the Annenberg Public Policy Center of the University of Pennsylvania.

3 Mar 2022

Vaccine News and Research

Latest Vaccine News and Research

How have human organoids been used in research to study SARS-CoV-2?

French study shows COVID vaccine efficacy 94% against severe outcomes

Study reveals the potential of novel antiviral drug combinations to stop COVID-19 spread

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

Delta and Omicron coinfections identified in France

Physicians' knowledge, attitudes, and preventative practices regarding the COVID-19 pandemic

Current progress in SARS-CoV-2 vaccine candidates

Study examines whether knowledge of virus-neutralizing antibody titer impacted wellness decision-making

Watch: California’s top health adviser on learning to live with covid

Study explores COVID-19 vaccine effectiveness in ankylosing spondylitis patients

Binding efficacy of SARS-CoV-2 S1 specific salivary antibodies to the Omicron and Delta variants

Virginia Tech-led researchers to investigate the transmission of flu in child care settings

Myocarditis and pericarditis in COVID-19 vaccine recipients

Combating COVID cytokine storm with targeted nucleic acid therapies

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

When teens blow off parents’ pleas to get vaccinated, the consequences can be deadly

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

COVID-19 and the life sciences; what have we learned and where are we going?

Over a third vaccinated-but-unboosted adults have reservations about vaccinating children

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in